Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01786187 · ClinicalTrials.gov registry record · Phase 1
The Symptom Experience Study in Persons With Non-Small Cell Lung Cancer
A Phase 1 study, sponsored by Michigan State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 87
- Enrollment target
NCT01786187: Completed Phase 1 study, sponsored by Michigan State University.
NCT01786187 is a Phase 1 study that has completed, run by Michigan State University. The registered enrollment target is 87 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (45% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01786187, a Phase 1 study, has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 87 participants
- Enrollment target
Study Summary
Little is known about the symptom experience of persons having undergone surgery for lung cancer. What we do know is that symptoms are common and can become severe and lasting. The main purpose of this study is two-fold: 1. To better understand the symptom experience of persons with lung cancer prior to surgery and for up to six weeks after returning home from the hospital. 2. To examine the role of a light physical activity program in persons who are undergoing surgery for lung cancer for the treatment of a specific symptom. The goals of this study include: * Collecting information about the participant's current and prior health history, symptoms, and health-related quality of life. * Assessing our ability to recruit participants to the study. * Assessing participant's level of participation. * Evaluating the participant's satisfaction with the program. We expect that patients after undergoing surgery for lung cancer during the recovery process will experience multiple symptoms. We also expect to find that a light intensity physical activity program will be feasible, acceptable, and show a positive impact on symptoms such as cancer-related fatigue and confidence for cancer-related fatigue self-management. Information gained from this randomized controlled trial study will be used to refine the design of future larger-scale studies targeting symptoms such as cancer-related fatigue for the lung cancer population.
Primary Outcome
Rates of recruitment were measured by the percentage of those eligible who enrolled.
Interventions
- BEHAVIORAL Light Physical Activity
- OTHER Symptom Experience Report
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-10 |
| Phase | Phase 1 |
What the finished NCT01786187 record still lists
NCT01786187 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (45% higher).
The record links to 0 conditions, and to 2 interventions - of which Light Physical Activity is the first listed.
NCT01786187 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01786187 about?
NCT01786187 is a clinical study titled "The Symptom Experience Study in Persons With Non-Small Cell Lung Cancer". Little is known about the symptom experience of persons having undergone surgery for lung cancer. What we do know is that symptoms are common and can become severe and lasting. The main purpose of this study is two-fold: 1. To better understand the symptom experience of persons with lung cancer pri...
What is the current status of trial NCT01786187?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 87 participants. The study started on 2013-01. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01786187?
The interventions under investigation include: Light Physical Activity (BEHAVIORAL), Symptom Experience Report (OTHER).
Who is sponsoring clinical trial NCT01786187?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01786187's enrollment target sits among peer trials
87 651st of 2000 higher than 1,349 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia